Total Positions
73
Quarter
2025 Q4
Top Holding
XBI (21.7%)
Top 10 Concentration
60.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 73
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 21.74% | — |
#1
Prev: #—
|
10.0 | 10,000,000 | no change |
NEW
|
10,000,000 | $1,219,300,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 5.22% | 4.38% |
#2
5
Prev: #7
|
4.1 | 1,798,126 | 18.5% |
P
S
|
11,526,971 | $293,015,603 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 5.10% | 7.24% |
#3
2
Prev: #1
|
2.1 | -1,354,086 | -32.6% |
P
S
|
2,800,000 | $285,992,000 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 5.10% | 3.29% |
#4
7
Prev: #11
|
2.0 | -104,029 | -2.5% |
P
S
|
4,111,782 | $285,974,438 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 4.39% | 4.98% |
#5
1
Prev: #6
|
3.8 | 4,034 | 0.1% |
P
S
|
3,004,034 | $245,970,304 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DVAX
DYNAVAX TECHNOL...
|
Healthcare | 4.31% | 4.36% |
#6
2
Prev: #8
|
1.7 | no change | no change |
P
S
|
15,726,349 | $241,871,248 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.78% | 6.60% |
#7
4
Prev: #3
|
1.6 | -963,002 | -22.4% |
P
S
|
3,336,998 | $212,032,853 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.74% | 3.05% |
#8
6
Prev: #14
|
3.6 | 250,000 | 27.8% |
P
S
|
1,150,000 | $210,036,000 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 3.47% | 5.05% |
#9
4
Prev: #5
|
1.4 | -250,382 | -3.1% |
P
S
|
7,750,000 | $194,680,000 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 3.29% | 3.02% |
#10
5
Prev: #15
|
3.4 | 1,000,000 | 33.3% |
P
S
|
4,000,000 | $184,560,000 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 3.14% | 2.86% |
#11
5
Prev: #16
|
3.3 | 297,530 | 7.5% |
P
S
|
4,246,440 | $175,930,009 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.55% | — |
#12
Prev: #—
|
3.0 | 2,821,135 | no change |
NEW
|
2,821,135 | $142,862,276 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.44% | 0.04% |
#13
41
Prev: #54
|
3.3 | 2,275,144 | 9153.3% |
P
S
|
2,300,000 | $136,689,000 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 2.40% | 6.95% |
#14
12
Prev: #2
|
1.1 | -2,108,144 | -55.4% |
P
S
|
1,700,000 | $134,487,000 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 2.38% | 1.56% |
#15
6
Prev: #21
|
3.0 | 979,431 | 16.2% |
P
S
|
7,036,455 | $133,481,551 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.83% | 1.54% |
#16
6
Prev: #22
|
2.7 | 99,790 | 3.2% |
P
S
|
3,249,790 | $102,498,377 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.75% | 3.89% |
#17
8
Prev: #9
|
0.8 | -3,861,723 | -32.4% |
P
S
|
8,070,414 | $97,974,826 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GRAL
GRAIL INC
|
Healthcare | 1.56% | — |
#18
Prev: #—
|
2.6 | 1,022,797 | no change |
NEW
|
1,022,797 | $87,541,195 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.40% | 3.24% |
#19
7
Prev: #12
|
0.7 | -2,855,616 | -53.1% |
P
S
|
2,524,833 | $78,572,803 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.33% | 1.48% |
#20
4
Prev: #24
|
0.5 | no change | no change |
P
S
|
3,352,804 | $74,633,417 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.24% | 1.82% |
#21
4
Prev: #17
|
2.5 | 203,978 | 11.3% |
P
S
|
2,003,978 | $69,558,076 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.17% | 1.42% |
#22
4
Prev: #26
|
0.5 | -493,271 | -18.6% |
P
S
|
2,161,510 | $65,515,368 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.10% | 1.74% |
#23
5
Prev: #18
|
0.5 | -389,858 | -32.5% |
P
S
|
810,142 | $61,967,762 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRMD
CORMEDIX INC
|
Healthcare | 1.09% | 0.16% |
#24
22
Prev: #46
|
2.7 | 4,774,076 | 954.8% |
P
S
|
5,274,076 | $61,337,504 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 1.08% | — |
#25
Prev: #—
|
2.4 | 4,610,071 | no change |
NEW
|
4,610,071 | $60,760,736 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 5.30% |
Sold All 😨
(Was: #4) |
0.3 | -4,000,978 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ETNB
89BIO INC
|
Unknown | 0.00% | 3.84% |
Sold All 😨
(Was: #10) |
0.3 | -9,356,171 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 3.18% |
Sold All 😨
(Was: #13) |
0.3 | -1,715,691 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 0.00% | 1.53% |
Sold All 😨
(Was: #23) |
0.3 | -1,000,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.00% | 0.95% |
Sold All 😨
(Was: #31) |
0.3 | -3,470,172 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 0.80% |
Sold All 😨
(Was: #32) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 0.79% |
Sold All 😨
(Was: #33) |
0.3 | -483,092 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #35) |
0.3 | -2,279,892 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.00% | 0.50% |
Sold All 😨
(Was: #37) |
0.3 | -1,250,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMAB
GENMAB A/S
|
Healthcare | 0.00% | 0.41% |
Sold All 😨
(Was: #40) |
0.3 | -481,267 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 0.00% | 0.20% |
Sold All 😨
(Was: #43) |
0.3 | -878,516 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
XENCOR INC
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #44) |
0.3 | -549,439 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEPG
PEPGEN INC
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #47) |
0.3 | -1,200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #50) |
0.3 | -2,568,613 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #52) |
0.3 | -105,085 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #53) |
0.3 | -144,600 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #55) |
0.3 | -259,014 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #56) |
0.3 | -509,789 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 73 holdings